+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Wearable Injectors Market Market by Type, Therapy, End-User, Regional Outlook - Global Forecast up to 2030

  • PDF Icon

    Report

  • 144 Pages
  • July 2024
  • Region: Global
  • IHR Insights
  • ID: 5985279
10% Free customization
10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

No more sore places or uncomfortable skin contact. Off-body injectors offer patients a more private and comfortable experience, particularly for individuals who are self-conscious about their looks or have sensitive skin. Usually, belts or clothing attachments are used to wear these injectors. These injectors allow for greater scheduling and dosing flexibility because they may deliver medication at exact times and durations. This is particularly beneficial for conditions that require extended release times or precise timing. Off-body devices lessen the possibility of dosages being missed due to pain or removal of patches. Certain medications even include smart connectivity that can track adherence and provide reminders, which helps to further improve dosage consistency. In addition to insulin, many other medications, such as complex biologics, analgesics, immunizations, and antibiotics, are also being researched for use in off-body injectors.

Rotary pumps provide unparalleled control and precision in the dispensing of drugs as compared to spring-based devices. Their fluid mechanics ensure continuous flow even with low-volume or viscous medications, minimizing error risk and optimizing therapeutic efficacy. This reliability is crucial for high-stakes medications like biologics, where dosing accuracy is paramount. With rotary pumps, there is no limit to one tune. They can adapt to a number of therapeutic applications because they can accommodate a larger range of drug viscosities and volumes than earlier technologies. Think of biologics, insulin, vaccinations, and analgesics - the possibilities are as limitless as the repertory of a skilled musician. Rotating pumps supplement the need for an efficient battery life by extending wear intervals and reducing the demand for frequent replacements. Enhanced patient contentment and comfort.

Wearable Injectors Market based on Type:

  • On-Body Injectors
  • Off-Body Injectors

Wearable Injectors Market based on Therapy:

  • Oncology
  • Autoimmune Disease
  • Diabetes
  • Cardiovascular Disease
  • Others

Wearable Injectors Market based on End-user:

  • Hospitals and Clinics
  • Home Care
  • Others

Wearable Injectors Market based on Geography:

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia Pacific (APAC)
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific (RoAPAC)
  • Latin America (LATAM)
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East and Africa (MEA)
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa
Wearable injectors help the hospital meet the need for more effective medication delivery. By facilitating the prompt and reliable administration of medication by nurses and other professionals, they reduce injection times and enhance workflows. This lowers expenses and frees up vital time for patient care by improving efficiency. Missed doses in hospital settings can result in treatment plans not being followed through on and increase readmission rates. With their longer wear lengths and clever reminders, wearable injectors provide consistent medicine delivery, decreasing missed doses and improving patient outcomes. Both patients and medical professionals applaud this improved adherence. Hospitals are placing an increasing amount of emphasis on patient autonomy and self-management. By enabling patients to administer their own prescriptions, wearable injectors allow patients greater autonomy - especially for chronic conditions requiring regular dose modifications.

The markets for wearable injectors in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa make up the global market. According to estimates, the wearable injector market in APAC would develop at the highest rate among regional markets in 2022. Asia Pacific has a sizable and aging population, which is increasing demand for chronic illness treatment programs. With its precise and practical medicine administration, wearable injectors effectively meet this need, particularly for the treatment of autoimmune diseases, diabetes, and pain. The IT sector is booming in the region, and several countries are leading the way in terms of output and innovation. This propels the market forward by promoting the rapid development and application of cutting-edge wearable injector technologies.

Leading players in this market include well-established and financially stable service providers of wearable injectors. These companies have been operating in the market for several years and possess a diversified product portfolio, advanced technologies, and strong global presence. Prominent companies in this market include Amgen Inc. (US), Medtronic PLC (Europe), Insulet Corporation (US), Tandem Diabetes Care, Inc. (US), United Therapeutics Corporation (US), Abbvie Inc. (US), Gerresheimer AG (Germany), Becton Dickinson and Company (US), West Pharmaceutical Services Inc. (US), Ypsomed AG (Switzerland), Enable Injections (US), Subcuject APS (Denmark), Cequr Simplicity (Switzerland), Mannkind Corporation (US), Sonceboz (Switzerland), CC Bio (Japan), Elcam Drug Delivery Devices (Israel), Stevanato Group (Italy), Debiotech SA (Switzerland), Bexson Biomedical (US), Nemera (France), LTS Lohmann Therapie Systeme AG (Germany), Kymanox Corporation (US), Novo Engineering (US), and Eoflow (South Korea).
  • This report illustrates the most vital attributes of the Wearable Injectors Market, which are driving and providing opportunities.
  • This research gives an in-depth analysis of the Wearable Injectors Market growth on the basis of several segments in the market.
  • This report presents the predictions of the past and present trends of the Wearable Injectors Market.
  • This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Wearable Injectors Market.

Table of Contents

1. Executive Summary
2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends
3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. Market characteristics
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. Type: Market Size & Analysis
5.1. Overview
5.2. On-Body Injectors
5.3. Off-Body Injectors
6. Therapy: Market Size & Analysis
6.1. Overview
6.2. Oncology
6.3. Autoimmune Disease
6.4. Diabetes
6.5. Cardiovascular Disease
6.6. Others
7. End-user: Market Size & Analysis
7.1. Overview
7.2. Hospitals and Clinics
7.3. Home Care
7.4. Others
8. Geography: Market Size & Analysis
8.1. Overview
8.2. North America (U.S., Mexico, Canada)
8.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe)
8.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC)
8.5. Latin America (Brazil, Argentina)
8.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa)
9. Competitive Landscape
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. Vendor Profiles
10.1. AMGEN INC.
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. BECTON, DICKINSON AND Company
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. DEXCOM, INC.
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. ENABLE INJECTIONS
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. INSULET CORPORATION
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. SENSILE MEDICAL
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. TANDEM DIABETES CARE, INC.
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. YPSOMED
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. BUHLER MOTOR GMBH
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. WEST PHARMACEUTICAL SERVICES, INC.
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. Analyst Opinion
12. Annexure
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
List of Tables
Table 1. Wearable Injectors Market Value, by Type, 2021-2030 (USD Billion)
Table 2. Wearable Injectors Market Value for On-Body Injectors, by Geography, 2021-2030 (USD Billion)
Table 3. Wearable Injectors Market Value for Off-Body Injectors, by Geography, 2021-2030 (USD Billion)
Table 4. Wearable Injectors Market Value, by Therapy, 2021-2030 (USD Billion)
Table 5. Wearable Injectors Market Value for Oncology, by Geography, 2021-2030 (USD Billion)
Table 6. Wearable Injectors Market Value for Autoimmune Disease, by Geography, 2021-2030 (USD Billion)
Table 7. Wearable Injectors Market Value for Diabetes, by Geography, 2021-2030 (USD Billion)
Table 8. Wearable Injectors Market Value for Cardiovascular Disease, by Geography, 2021-2030 (USD Billion)
Table 9. Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 10. Wearable Injectors Market Value for Hospitals and Clinics, 2021-2030 (USD Billion)
Table 11. Wearable Injectors Market Value for Home Care, by Geography, 2021-2030 (USD Billion)
Table 12. Wearable Injectors Market Value for Others, 2021-2030 (USD Billion)
Table 13. North America Wearable Injectors Market Value, by Country, 2021-2030 (USD Billion)
Table 14. North America Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 15. North America Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 16. North America Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 17. U.S Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 18. U.S Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 19. U.S Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 20. Canada Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 21. Canada Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 22. Canada Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 23. Mexico Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 24. Mexico Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 25. Mexico Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 26. Europe Wearable Injectors Market Value, by Country, 2021-2030 (USD Billion)
Table 27. Europe Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 28. Europe Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 29. Europe Wearable Injectors Market Value, End Use Industries, 2021-2030 (USD Billion)
Table 30. Germany Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 31. Germany Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 32. Germany Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 33. U.K Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 34. U.K Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 35. U.K Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 36. France Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 37. France Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 38. France Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 39. Italy Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 40. Italy Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 41. Italy Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 42. Spain Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 43. Spain Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 44. Spain Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 45. Roe Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 46. Roe Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 47. Roe Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 48. Asia-Pacific Wearable Injectors Market Value, by Country, 2021-2030 (USD Billion)
Table 49. Asia-Pacific Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 50. Asia-Pacific Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 51. Asia-Pacific Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 52. China Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 53. China Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 54. China Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 55. India Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 56. India Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 57. India Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 58. Japan Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 59. Japan Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 60. Japan Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 61. Rest of APAC Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 62. Rest of APAC Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 63. Rest of APAC Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 64. Latin America Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 65. Latin America Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 66. Latin America Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 67. Brazil Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 68. Brazil Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 69. Brazil Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 70. Argentina Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 71. Argentina Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 72. Argentina Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 73. Middle East and Africa Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 74. Middle East and Africa Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 75. Middle East and Africa Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 76. Saudi Arabia Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 77. Saudi Arabia Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 78. Saudi Arabia Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 79. Uae Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 80. Uae Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 81. Uae Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 82. Rest of Middle East and Africa Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Table 83. Rest of Middle East and Africa Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Table 84. Rest of Middle East and Africa Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Table 85. Amgen Inc.: Financials
Table 86. Amgen Inc.: Products & Services
Table 87. Amgen Inc.: Recent Developments
Table 88. Becton, Dickinson and Company: Financials
Table 89. Becton, Dickinson and Company: Products & Services
Table 90. Becton, Dickinson and Company: Recent Developments
Table 91. Dexcom, Inc.: Financials
Table 92. Dexcom, Inc.: Products & Services
Table 93. Dexcom, Inc.: Recent Developments
Table 94. Enable Injections: Financials
Table 95. Enable Injections: Products & Services
Table 96. Enable Injections: Recent Developments
Table 97. Insulet Corporation: Financials
Table 98. Insulet Corporation: Products & Services
Table 99. Insulet Corporation: Recent Developments
Table 100. Sensile Medical: Financials
Table 101. Sensile Medical: Products & Services
Table 102. Sensile Medical: Recent Developments
Table 103. Tandem Diabetes Care, Inc.: Financials
Table 104. Tandem Diabetes Care, Inc.: Products & Services
Table 105. Tandem Diabetes Care, Inc.: Developments
Table 106. Ypsomed: Financials
Table 107. Ypsomed: Products & Services
Table 108. Ypsomed: Recent Developments
Table 109. Buhler Motor Gmbh: Financials
Table 110. Buhler Motor Gmbh: Products & Services
Table 111. Buhler Motor Gmbh: Recent Developments
Table 112. West Pharmaceutical Services, Inc.: Financials
Table 113. West Pharmaceutical Services, Inc.: Products & Services
Table 114. West Pharmaceutical Services, Inc.: Recent Developments
List of Figures
Chart. 1. Wearable Injectors Market Value, by Type, 2021-2030 (USD Billion)
Chart. 2. Wearable Injectors Market Value for On-Body Injectors, by Geography, 2021-2030 (USD Billion)
Chart. 3. Wearable Injectors Market Value for Off-Body Injectors, by Geography, 2021-2030 (USD Billion)
Chart. 4. Wearable Injectors Market Value, by Therapy, 2021-2030 (USD Billion)
Chart. 5. Wearable Injectors Market Value for Oncology, by Geography, 2021-2030 (USD Billion)
Chart. 6. Wearable Injectors Market Value for Autoimmune Disease, by Geography, 2021-2030 (USD Billion)
Chart. 7. Wearable Injectors Market Value for Diabetes, by Geography, 2021-2030 (USD Billion)
Chart. 8. Wearable Injectors Market Value for Cardiovascular Disease, by Geography, 2021-2030 (USD Billion)
Chart. 9. Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 10. Wearable Injectors Market Value for Hospitals and Clinics, 2021-2030 (USD Billion)
Chart. 11. Wearable Injectors Market Value for Home Care, by Geography, 2021-2030 (USD Billion)
Chart. 12. Wearable Injectors Market Value for Others, 2021-2030 (USD Billion)
Chart. 13. North America Wearable Injectors Market Value, by Country, 2021-2030 (USD Billion)
Chart. 14. North America Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 15. North America Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 16. North America Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 17. U.S Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 18. U.S Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 19. U.S Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 20. Canada Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 21. Canada Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 22. Canada Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 23. Mexico Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 24. Mexico Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 25. Mexico Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 26. Europe Wearable Injectors Market Value, by Country, 2021-2030 (USD Billion)
Chart. 27. Europe Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 28. Europe Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 29. Europe Wearable Injectors Market Value, End Use Industries, 2021-2030 (USD Billion)
Chart. 30. Germany Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 31. Germany Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 32. Germany Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 33. U.K Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 34. U.K Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 35. U.K Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 36. France Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 37. France Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 38. France Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 39. Italy Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 40. Italy Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 41. Italy Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 42. Spain Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 43. Spain Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 44. Spain Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 45. Roe Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 46. Roe Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 47. Roe Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 48. Asia-Pacific Wearable Injectors Market Value, by Country, 2021-2030 (USD Billion)
Chart. 49. Asia-Pacific Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 50. Asia-Pacific Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 51. Asia-Pacific Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 52. China Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 53. China Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 54. China Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 55. India Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 56. India Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 57. India Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 58. Japan Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 59. Japan Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 60. Japan Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 61. Rest of APAC Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 62. Rest of APAC Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 63. Rest of APAC Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 64. Latin America Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 65. Latin America Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 66. Latin America Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 67. Brazil Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 68. Brazil Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 69. Brazil Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 70. Argentina Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 71. Argentina Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 72. Argentina Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 73. Middle East and Africa Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 74. Middle East and Africa Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 75. Middle East and Africa Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 76. Saudi Arabia Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 77. Saudi Arabia Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 78. Saudi Arabia Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 79. Uae Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 80. Uae Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 81. Uae Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 82. Rest of Middle East and Africa Wearable Injectors Market Value, by Technology, 2021-2030 (USD Billion)
Chart. 83. Rest of Middle East and Africa Wearable Injectors Market Value, by Indication, 2021-2030 (USD Billion)
Chart. 84. Rest of Middle East and Africa Wearable Injectors Market Value, by End-User, 2021-2030 (USD Billion)
Chart. 85. Amgen Inc.: Financials
Chart. 86. Amgen Inc.: Products & Services
Chart. 87. Amgen Inc.: Recent Developments
Chart. 88. Becton, Dickinson and Company: Financials
Chart. 89. Becton, Dickinson and Company: Products & Services
Chart. 90. Becton, Dickinson and Company: Recent Developments
Chart. 91. Dexcom, Inc.: Financials
Chart. 92. Dexcom, Inc.: Products & Services
Chart. 93. Dexcom, Inc.: Recent Developments
Chart. 94. Enable Injections: Financials
Chart. 95. Enable Injections: Products & Services
Chart. 96. Enable Injections: Recent Developments
Chart. 97. Insulet Corporation: Financials
Chart. 98. Insulet Corporation: Products & Services
Chart. 99. Insulet Corporation: Recent Developments
Chart. 100. Sensile Medical: Financials
Chart. 101. Sensile Medical: Products & Services
Chart. 102. Sensile Medical: Recent Developments
Chart. 103. Tandem Diabetes Care, Inc.: Financials
Chart. 104. Tandem Diabetes Care, Inc.: Products & Services
Chart. 105. Tandem Diabetes Care, Inc.: Developments
Chart. 106. Ypsomed: Financials
Chart. 107. Ypsomed: Products & Services
Chart. 108. Ypsomed: Recent Developments
Chart. 109. Buhler Motor Gmbh: Financials
Chart. 110. Buhler Motor Gmbh: Products & Services
Chart. 111. Buhler Motor Gmbh: Recent Developments
Chart. 112. West Pharmaceutical Services, Inc.: Financials
Chart. 113. West Pharmaceutical Services, Inc.: Products & Services
Chart. 114. West Pharmaceutical Services, Inc.: Recent Developments

Companies Mentioned

  • AMGEN INC.
  • Becton, Dickinson and Company
  • DEXCOM INC.
  • ENABLE INJECTIONS
  • INSULET CORPORATION
  • SENSILE MEDICAL
  • TANDEM DIABETES CARE INC.
  • YPSOMED
  • BUHLER MOTOR GMBH
  • WEST PHARMACEUTICAL SERVICES INC.